Skip to main content
. 2022 Jan 23;14(2):265. doi: 10.3390/pharmaceutics14020265

Figure 4.

Figure 4

Figure 4 illustrates the intravitreal drug concentration and free VEGF proportion in a patient treated with q8 (a) or q12 (b) 2 mg aflibercept injections.